Charles River Laboratories International (CRL) Operating Leases (2019 - 2025)

Charles River Laboratories International (CRL) has reported Operating Leases for 7 consecutive years, with $434.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Operating Leases fell 10.28% year-over-year to $434.0 million; the TTM figure through Dec 2025 stood at $434.0 million (down 10.28% YoY), while the FY2025 annual figure was $434.0 million, down 10.28% from the prior year.
• Operating Leases came in at $434.0 million for Q4 2025 at Charles River Laboratories International, down from $443.2 million in the prior quarter.
• The five-year high for Operating Leases was $483.8 million in Q4 2024, with the low at $173.0 million in Q1 2021.
• Average Operating Leases over 5 years is $383.2 million, with a median of $418.1 million recorded in 2023.
• Across the five-year window, Operating Leases soared 84.07% in 2021 and fell 10.28% in 2025, its largest moves.
• Year by year, Operating Leases stood at $286.2 million in 2021, then surged by 52.41% to $436.3 million in 2022, then rose by 8.68% to $474.1 million in 2023, then rose by 2.03% to $483.8 million in 2024, then fell by 10.28% to $434.0 million in 2025.
• According to Business Quant data, Operating Leases over the past three periods registered $434.0 million, $443.2 million, and $453.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.